PIK3CA and neoplasm: The presence of a PIK3CA mutation is common in BC; however, the associated prognostic and predictive value is uncertain in the current clinical context due to variations in the source of tumor DNA, times when samples are obtained for testing during the disease course, and analytical methodologies and their respective sensitivity/specificity, as well as which hotspots are detected by the test.